Marasini N, Er G, Fu C, Subasic CN, Ibrahim J, Skwarczynski M, Toth I, Whittaker AK, Kaminskas LM
In obesity treatment, adherence is more variable and often more fragile
Consumers allege in lawsuits that these companies sold compounded or mislabeled semaglutide products without providing informed consent about the dangers
Its effectiveness is underscored by clinical trials demonstrating significant weight loss outcomes
Nausea, reflux, constipation, and bloating can disrupt sleep, reduce intake, and make movement feel harder all of which feeds fatigue
Kijlstra A, Tian Y, Kelly ER, Berendschot TT